$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Hematology
Hematology
吉瑞替尼在治疗白血病这方面疗效怎么样?
2025-10-19 11:44:20
Check Details
靶向药依维替尼用药注意事项
2025-10-19 11:44:20
Check Details
依维替尼是急性骨髓性白血病患者的福音
2025-10-19 11:44:20
Check Details
急性骨髓性白血病一线用药-依维替尼
2025-10-19 11:44:20
Check Details
新药依维替尼适应症及用法用量
2025-10-19 11:44:20
Check Details
FLT3抑制剂吉瑞替尼哪里有售?
2025-10-19 11:44:20
Check Details
依维替尼治疗急性骨髓性白血病的效果
2025-10-19 11:44:20
Check Details
急性髓系白血病新药吉瑞替尼在中国上市了吗?
2025-10-19 11:44:20
Check Details
吉瑞替尼的适用人群
2025-10-19 11:44:20
Check Details
吉瑞替尼治疗急性髓系白血病的效果如何?
2025-10-19 11:44:20
Check Details
苯达莫司汀是化疗药还是靶向药?
2025-10-19 11:44:20
Check Details
苯达莫司汀中国上市价格
2025-10-19 11:44:20
Check Details
1
2
...
572
573
574
575
576
577
578
...
935
936
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Olutasidenib: Mechanism of Action and Clinical Guide for IDH1-Mutated AML
2
Gilteritinib: Efficacy, Medication Guide and Latest Advances for FLT3-Mutated AML
3
Common Adverse Reactions and Clinical Safety Management of Gilteritinib (Xospata)
4
Adverse Reaction Profile and Clinical Safety Management of Idelalisib
5
Clinical Significance of Platelet Recovery During Revumenib (Menin Inhibitor) Therapy
6
A Key Therapeutic Breakthrough Against T315I-Mutant CML
7
Tafasitamab: An Fc-Enhanced CD19-Targeted Immunotherapy for B-Cell Malignancies
8
Tafasitamab and Lenalidomide Combination Therapy Guide
9
Pirtobrutinib (Jaypirca) Medication Guide: Overcoming BTK Resistance & Safety Management
10
Gilteritinib Professional Medication Guide & Dosage Management
11
Pirtobrutinib: A Novel Non-Covalent BTK Inhibitor for Relapsed Hematologic Malignancies
12
Clinical Application and Safety Monitoring of Revumenib (Menin Inhibitor) in Acute Leukemia